Filing Details

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

CUSIP No. 003830106

13D

 

  * Based on 15,624,123 shares of Class A Common Stock of $.01 par value (“Common Stock”) of the Issuer outstanding as of February 26, 2021 as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

CUSIP No. 003830106

13D

  * Based on 15,624,123 shares of Class A Common Stock of $.01 par value (“Common Stock”) of the Issuer outstanding as of February 26, 2021 as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

 

CUSIP No. 003830106

13D

  * Based on 15,624,123 shares of Class A Common Stock of $.01 par value (“Common Stock”) of the Issuer outstanding as of February 26, 2021 as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

CUSIP No. 003830106

13D

* Based on 15,624,123 shares of Class A Common Stock of $.01 par value (“Common Stock”) of the Issuer outstanding as of February 26, 2021 as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

 

 

CUSIP No. 003830106

13D

* Based on 15,624,123 shares of Class A Common Stock of $.01 par value (“Common Stock”) of the Issuer outstanding as of February 26, 2021 as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

This Amendment No. 2 to Schedule 13D amends and supplements the Schedule 13D filed by (i) Angelo, Gordon & Co., L.P., a Delaware limited partnership (“Angelo Gordon”), (ii) AG GP LLC (formerly AG Partners, LLC), a Delaware limited liability company (“AG GP”), (iii) JAMG LLC a Delaware limited liability company (“JAMG”), (iv) Josh Baumgarten and (iv) Adam Schwartz with the Securities and Exchange Commission (the “SEC”) on February 4, 2021, as amended by Amendment No. 1 to Schedule 13D, filed on March 25, 2021 (the “Schedule 13D”).

This Amendment No. 2 amends and supplements the Schedule 13D as specifically set forth herein.

All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable.

(a) This statement is filed by: (i) Angelo, Gordon & Co., L.P., a Delaware limited partnership (“Angelo Gordon”), (ii) AG GP LLC (formerly AG Partners, LLC), a Delaware limited liability company (“AG GP”), (iii) JAMG LLC a Delaware limited liability company (“JAMG”), (iv) Josh Baumgarten and (v) Adam Schwartz (collectively with Angelo Gordon, AG GP, JAMG and Mr. Baumgarten, the “Reporting Persons”).

Angelo Gordon, in its capacity as investment manager to certain managed accounts and investment fund vehicles (collectively, the “Accounts”), has sole power to vote all shares of Common Stock held in the Accounts and to dispose of all shares of Common Stock held in the Accounts. Mr. Baumgarten and Mr. Schwartz are the managing members of JAMG, which is no longer the managing member of AG GP and, therefore, JAMG is no longer a beneficial owner. Mr. Baumgarten and Mr. Schwartz are the managing members of AG GP, which is the sole general partner of Angelo Gordon and Mr. Baumgarten and Mr. Schwartz are the co-chief executive officers of Angelo Gordon. Each of Mr. Baumgarten, Mr. Schwartz and AG GP may be deemed to control Angelo Gordon.

(b) The business address of the Reporting Persons is 245 Park Avenue, 26th Floor, New York, New York 10167.

(c) The principal business of Angelo Gordon is the management of the assets and activities of the Accounts. The principal business of AG GP is acting as the general partner of Angelo Gordon.  The principal business of Mr. Baumgarten and Mr. Schwartz is acting as the co-managing members of AG GP and the co-chief executive officers of Angelo Gordon.

(d) None of the Reporting Persons nor any of the Accounts have, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) None of the Reporting Persons nor any of the Accounts have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Angelo Gordon is a Delaware limited partnership. AG GP is a Delaware limited liability company. JAMG is a Delaware limited liability company. Mr. Baumgarten is a United States citizen. Mr. Schwartz is a United States citizen.

The Reporting Persons purchased 1,152,122 shares of Common Stock on behalf of the Accounts in open market transactions through a broker using the working capital of the Accounts. The aggregate purchase price of such shares of Common Stock purchased in the open market and directly held by the Accounts was approximately $3,262,077.

Purchases of some securities for certain Accounts were effected through margin accounts maintained with brokers, which may extend margin credit as and when required to open or carry positions in the margin accounts, subject to applicable federal margin regulations, stock exchange rules and the brokers’ credit policies. In such instances, the positions held in the margin accounts may be pledged as collateral security for the repayment of debit balances in the accounts of the Accounts.

Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference.  Such information is based on 15,624,123 shares of Common Stock outstanding as of February 26, 2021, as reported in the Issuer’s Form 10-K filed with the SEC on March 1, 2021.

Angelo Gordon, in its capacity as investment manager to the Accounts, has sole power to vote 1,152,122 shares of Common Stock and the power to dispose of 1,152,122 shares of Common Stock held in the Accounts. As the general partner of Angelo Gordon, AG GP may be deemed to have the sole power to vote 1,152,122 shares of Common Stock and the power to dispose of 1,152,122 shares of Common Stock held in the Accounts. JAMG is no longer the managing member of AG GP and, therefore, has no beneficial ownership. As the co-managing member of AG GP and the co-chief executive officer of Angelo Gordon, Mr. Baumgarten may be deemed to have shared power to vote 1,152,122 shares of Common Stock and the shared power to dispose of 1,152,122 shares of Common Stock held in the Accounts. As the co-managing member of AG GP and the co-chief executive officer of Angelo Gordon, Mr. Schwartz may be deemed to have shared power to vote 1,152,122 shares of Common Stock and the shared power to dispose of 1,152,122 shares of Common Stock held in the Accounts.

(c) Transactions in the shares of Common Stock by the Reporting Persons since March 25, 2021 are listed in Annex A attached hereto, which is incorporated herein by reference.

(d) Not Applicable.

(e) Not Applicable.

Dated: April 22, 2021

The following table sets forth all transactions by the Reporting Persons (on behalf of the Accounts) with respect to shares of Common Stock effected since March 25, 2021, inclusive of any transactions effected through 9:00 a.m., New York City time, on April 22, 2021. Except as otherwise noted below, all such transactions were purchases of Common Stock effected in the open market, and the table excludes commissions paid in per share prices.

 

(1) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.64, inclusive. The reporting persons undertake to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11) and (12).

(2) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.98 to $18.25, inclusive.

(3) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.08 to $18.25, inclusive.

(4) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.50, inclusive.

(5) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.36 to $20.89, inclusive.

(6) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.06 to $19.65, inclusive.

(7) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.23 to $19.76, inclusive.

(8) The sale price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.47, inclusive.